Rational Vaccines Announces a Clinical Study of the Frequency of Symptomatic Herpes Simplex Type 1 and 2 (HSV-1 and HSV-2) Virus in HIV Patients

/PRNewswire/ -- Rational Vaccines, a company focused on revolutionizing the treatment and prevention of herpes to eradicate the disease, today announced the...

Related Keywords

Los Angeles ,California ,United States ,Jorgee Rodriguez ,Kerstin Westritschnig ,Debra Barile ,Global Research Institute In Los Angeles ,World Health Organization ,Observational Study ,Global Research Institute ,Rational Vaccines ,Herpes Simplex Virus ,